Foghorn Therapeutics's total assets for Q3 2025 were $204.96M, a decrease of -9.40% from the previous quarter. FHTX total liabilities were $294.62M for the fiscal quarter, a -2.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.